Benefits and challenges of creating veterinary antibiograms for empiric antimicrobial selection in support of antimicrobial stewardship and advancement of one-health goals.

Antibiograms are important tools for antimicrobial stewardship that are often underutilized in veterinary medicine. Antibiograms summarize cumulative antimicrobial susceptibility testing (AST) data for specific pathogens over a defined time period; in veterinary medicine, they are often stratified by host species and site of infection. They can aid practitioners with empiric therapy choices and assessment of antimicrobial resistance trends within a population in support of one-health goals for antimicrobial stewardship. For optimal application, consideration must be given to the number of isolates used, the timeframe of sample collection, laboratory analytical methodology, and the patient population contributing to the data (eg, treatment history, geographic region, and production type). There are several limitations to veterinary antibiograms, including a lack of breakpoint availability for bacterial species, a lack of standardization of laboratory methodology and technology for culture and AST, and a lack of funding to staff veterinary diagnostic laboratories at a level that supports antibiogram development and education. It is vital that veterinarians who use antibiograms understand how to apply them in practice and receive relevant information pertaining to the data to utilize the most appropriate antibiogram for their patients. This paper explores the benefits and challenges of developing and using veterinary antibiograms and proposes strategies to enhance their applicability and accuracy. Further detail regarding the application of veterinary antibiograms by privately practicing clinicians is addressed in the companion Currents in One Health article by Lorenz et al (JAVMA, September 2023).

[1]  Renee R. Anderson,et al.  Effect of antimicrobial administration on fecal microbiota of critically ill dogs: dynamics of antimicrobial resistance over time , 2022, Animal microbiome.

[2]  J. Kwong,et al.  Multi-site implementation of whole genome sequencing for hospital infection control: A prospective genomic epidemiological analysis , 2022, The Lancet regional health. Western Pacific.

[3]  K. R. Villumsen,et al.  Genomic Analysis of Escherichia coli Longitudinally Isolated from Broiler Breeder Flocks after the Application of an Autogenous Vaccine , 2022, Microorganisms.

[4]  Third joint inter‐agency report on integrated analysis of consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food‐producing animals in the EU/EEA , 2021, EFSA journal. European Food Safety Authority.

[5]  Dominika A. Jurkovic,et al.  Genomics accurately predicts antimicrobial resistance in Staphylococcus pseudintermedius collected as part of Vet-LIRN resistance monitoring. , 2021, Veterinary microbiology.

[6]  A. Stewart,et al.  Cumulative antibiogram and multidrug-resistant organisms in a regional equine referral hospital , 2020, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[7]  B. Tenhagen,et al.  Antibiotikaresistenz von E. coli aus Rinderpopulationen in Deutschland , 2020, Tierärztliche Praxis Ausgabe G: Großtiere / Nutztiere.

[8]  I. Morrissey,et al.  Antimicrobial susceptibility of nine udder pathogens recovered from bovine clinical mastitis milk in Europe 2015-2016: VetPath results. , 2020, Veterinary microbiology.

[9]  B. Lubbers,et al.  Antimicrobial Susceptibility Testing of Bacteria of Veterinary Origin , 2018, Microbiology spectrum.

[10]  M. Erdman,et al.  A survey of methods used for antimicrobial susceptibility testing in veterinary diagnostic laboratories in the United States , 2017, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[11]  S. Schwarz,et al.  Extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolates collected from diseased food-producing animals in the GERM-Vet monitoring program 2008-2014. , 2017, Veterinary microbiology.

[12]  L. Matukas,et al.  Cumulative Antimicrobial Susceptibility Data from Intensive Care Units at One Institution: Should Data Be Combined? , 2016, Journal of Clinical Microbiology.

[13]  G. Jacoby,et al.  Mechanisms of drug resistance: quinolone resistance , 2015, Annals of the New York Academy of Sciences.

[14]  A. Hoet,et al.  Antimicrobial drug use in dogs prior to admission to a veterinary teaching hospital. , 2012, Journal of the American Veterinary Medical Association.

[15]  A. MacGowan,et al.  The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[16]  G. Prod'Hom,et al.  Comparison of hospital-wide and unit-specific cumulative antibiograms in hospital- and community-acquired infection , 2010, Infection.

[17]  T. Vernet,et al.  Penicillin-binding proteins and beta-lactam resistance. , 2008, FEMS microbiology reviews.

[18]  L. Wieler,et al.  Antimicrobial susceptibility of Escherichia coli from swine, horses, dogs and cats as determined in the BfT-GermVet monitoring program 2004-2006. , 2007, Berliner und Munchener tierarztliche Wochenschrift.

[19]  B. Glick,et al.  Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. , 2019, Biotechnology advances.